AN2 Therapeutics, Inc.【ANTX】

Market cap

$141.52M

P/E ratio

	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	27	16	21
Short-term investments	69	92	62
Prepaid expenses and other current assets	3	3	3
Right-of-use asset, net	0	-	-
Total current assets	99	111	86
Long-term investments	3	27	5
Other assets, long-term	1	1	1
Total assets	103	139	92
Accounts payable	2	3	3
Accrued compensation	2	4	2
Accrued liabilities	3	7	4
Other current liabilities	-	1	1
Operating lease liabilities	0	-	-
Options Subject To Repurchase Short Term	0	0	-
Total current liabilities	7	14	-
Options Subject To Repurchase Long Term	0	-	-
Total liabilities	7	14	10
Additional paid-in capital	185	279	288
Accumulated other comprehensive gain	-0	0	0
Accumulated deficit	-90	-154	-206
Total stockholders' equity	95	125	82
Total liabilities and stockholders' equity	103	139	92